Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection

Our understanding of HIV infection has greatly advanced since the discovery of the virus in 1983. Treatment options have improved the quality of life of people living with HIV/AIDS, turning it from a fatal disease into a chronic, manageable infection. Despite all this progress, a cure remains elusiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbosu, Esinam E., Ledger, Scott, Kelleher, Anthony D., Wen, Jing, Ahlenstiel, Chantelle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324444/
https://www.ncbi.nlm.nih.gov/pubmed/35890248
http://dx.doi.org/10.3390/pharmaceutics14071352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324444/
https://www.ncbi.nlm.nih.gov/pubmed/35890248
http://dx.doi.org/10.3390/pharmaceutics14071352

Ejemplares similares